Regulation & law · 23/11/2015Updated: 10/17/2026 · 1 min read
U.S. Government to Grant Exclusive License for Malaria Research Patent
Summary
The U.S. government is set to grant an exclusive, royalty-bearing license to MalarVx, Inc. for its patent on developing malaria sporozoites in vitro, filed in 2015.
Original source language: Federal Register — All DocumentsOpen original release →